Just Released: "Non-Small Cell Lung Carcinoma - Pipeline Review, H2 2013"
Global Markets Direct's, 'Non-Small Cell Lung Carcinoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Non-Small Cell Lung Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non-Small Cell Lung Carcinoma. Non-Small Cell Lung Carcinoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release